Seeing Is Believing
Stemline Therapeutics's activity chart (see below) currently has 41 price targets and 40 ratings on display.
Analysts average stock forecasts to be materialized ratio is 8.57% with an average time for these price targets to be met of 11.6 days.
Most recent stock forecast was given by from LADENBURG on 05-May-2020. First documented stock forecast 29-Aug-2013.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Mar-2017
$12.5
$0.67 (5.66%)
$41
6 years 4 months 18 days ago
(05-May-2020)
0/2 (0%)
$0.41 (3.39%)
Hold Since 05-May-2020
$12.5
$0.67 (5.66%)
6 years 4 months 18 days ago
(05-May-2020)
0/5 (0%)
$0.41 (3.39%)
Hold Since 04-May-2020
$11
$-0.83 (-7.02%)
6 years 4 months 19 days ago
(04-May-2020)
0/4 (0%)
$-1.11 (-9.17%)
Buy Since 24-Dec-2019
$10
6 years 4 months 19 days ago
(04-May-2020)
1/2 (50%)
$5.6 (127.27%)
38
Buy Since 26-Nov-2018
$9
$-2.83 (-23.92%)
$25
6 years 6 months 7 days ago
(16-Mar-2020)
1/7 (14.29%)
$4.94 (121.67%)
49
What is STML (Stemline Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on STML (Stemline Therapeutics)?
Which analyst has the most public recommendations on STML (Stemline Therapeutics)?
Which analyst is the currently most bullish on STML (Stemline Therapeutics)?
Which analyst is the currently most reserved on STML (Stemline Therapeutics)?